Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13059-014-0431-1.

Title:
Genome-driven integrated classification of breast cancer validated in over 7,500 samples | Genome Biology
Description:
Background IntClust is a classification of breast cancer comprising 10 subtypes based on molecular drivers identified through the integration of genomic and transcriptomic data from 1,000 breast tumors and validated in a further 1,000. We present a reliable method for subtyping breast tumors into the IntClust subtypes based on gene expression and demonstrate the clinical and biological validity of the IntClust classification. Results We developed a gene expression-based approach for classifying breast tumors into the ten IntClust subtypes by using the ensemble profile of the index discovery dataset. We evaluate this approach in 983 independent samples for which the combined copy-number and gene expression IntClust classification was available. Only 24 samples are discordantly classified. Next, we compile a consolidated external dataset composed of a further 7,544 breast tumors. We use our approach to classify all samples into the IntClust subtypes. All ten subtypes are observable in most studies at comparable frequencies. The IntClust subtypes are significantly associated with relapse-free survival and recapitulate patterns of survival observed previously. In studies of neo-adjuvant chemotherapy, IntClust reveals distinct patterns of chemosensitivity. Finally, patterns of expression of genomic drivers reported by TCGA (The Cancer Genome Atlas) are better explained by IntClust as compared to the PAM50 classifier. Conclusions IntClust subtypes are reproducible in a large meta-analysis, show clinical validity and best capture variation in genomic drivers. IntClust is a driver-based breast cancer classification and is likely to become increasingly relevant as more targeted biological therapies become available.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Photography

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

intclust, cancer, breast, expression, subtypes, gene, classification, subtype, pubmed, study, data, genes, studies, additional, file, article, metabric, google, scholar, samples, tumors, number, survival, pam, copy, based, clinical, models, cas, classifier, external, cell, molecular, genomic, scmgene, analysis, tumor, figure, method, dataset, central, explained, comparison, lines, nature, profiles, patterns, tcga, patients, size,

Topics {✒️}

genome-driven integrated classification genome-wide driver-based classification org/web/packages/boot/index european genome-phenome archive distant metastasis-free survival org/web/packages/] waldron receiver-operating-characteristic curves kaplan-meier survival plots copy number-driven genes long-term clinical management long-term clinical benefit data-driven approaches designed article download pdf luminal immune-positive subgroup heterogeneity search search receive neo-adjuvant chemotherapy mutations deemed ‘m-class adjusted r-squared statistic driver-based molecular taxonomy high-resolution copy-number er-negative breast cancer studies received neo-adjuvant adjusted r-squared statistics gene expression profile average gene-expression profiles node-negative breast cancer carlos caldas r-squared values explained er-positive breast cancer cancer research uk copy number-based classifier subgroups comprise high-risk /pubs/sbtpaper] copy number profiles copy-number profiles author information authors receiver operating characteristic shah sp privacy choices/manage cookies relapse-free survival gene expression-based classifier expression-based intclust classification cancer genome atlas cancer genome landscapes late-stage ovarian cancer lawrence ms view cross-platform normalization methods long-term survival [30] long term survival

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Genome-driven integrated classification of breast cancer validated in over 7,500 samples
         description:IntClust is a classification of breast cancer comprising 10 subtypes based on molecular drivers identified through the integration of genomic and transcriptomic data from 1,000 breast tumors and validated in a further 1,000. We present a reliable method for subtyping breast tumors into the IntClust subtypes based on gene expression and demonstrate the clinical and biological validity of the IntClust classification. We developed a gene expression-based approach for classifying breast tumors into the ten IntClust subtypes by using the ensemble profile of the index discovery dataset. We evaluate this approach in 983 independent samples for which the combined copy-number and gene expression IntClust classification was available. Only 24 samples are discordantly classified. Next, we compile a consolidated external dataset composed of a further 7,544 breast tumors. We use our approach to classify all samples into the IntClust subtypes. All ten subtypes are observable in most studies at comparable frequencies. The IntClust subtypes are significantly associated with relapse-free survival and recapitulate patterns of survival observed previously. In studies of neo-adjuvant chemotherapy, IntClust reveals distinct patterns of chemosensitivity. Finally, patterns of expression of genomic drivers reported by TCGA (The Cancer Genome Atlas) are better explained by IntClust as compared to the PAM50 classifier. IntClust subtypes are reproducible in a large meta-analysis, show clinical validity and best capture variation in genomic drivers. IntClust is a driver-based breast cancer classification and is likely to become increasingly relevant as more targeted biological therapies become available.
         datePublished:2014-08-28T00:00:00Z
         dateModified:2014-08-28T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1186/s13059-014-0431-1
         keywords:
            Molecular Subtype
            Copy Number Data
            Cancer Cell Line Encyclopedia
            External Study
            Subtype Assignment
            Animal Genetics and Genomics
            Human Genetics
            Plant Genetics and Genomics
            Microbial Genetics and Genomics
            Bioinformatics
            Evolutionary Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig4_HTML.jpg
         isPartOf:
            name:Genome Biology
            issn:
               1474-760X
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:H Raza Ali
               affiliation:
                     name:University of Cambridge, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Cambridge
                     address:
                        name:Department of Pathology, University of Cambridge, Cambridge, UK
                        type:PostalAddress
                     type:Organization
                     name:Cambridge University Hospitals NHS
                     address:
                        name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Oscar M Rueda
               affiliation:
                     name:University of Cambridge, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suet-Feung Chin
               affiliation:
                     name:University of Cambridge, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christina Curtis
               affiliation:
                     name:University of Southern California
                     address:
                        name:Keck School of Medicine, University of Southern California, California, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark J Dunning
               affiliation:
                     name:University of Cambridge, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Samuel AJR Aparicio
               affiliation:
                     name:British Columbia Cancer Research Centre
                     address:
                        name:Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos Caldas
               affiliation:
                     name:University of Cambridge, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Cambridge, Addenbrooke’s Hospital
                     address:
                        name:Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
                        type:PostalAddress
                     type:Organization
                     name:Cambridge University Hospitals NHS
                     address:
                        name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Genome-driven integrated classification of breast cancer validated in over 7,500 samples
      description:IntClust is a classification of breast cancer comprising 10 subtypes based on molecular drivers identified through the integration of genomic and transcriptomic data from 1,000 breast tumors and validated in a further 1,000. We present a reliable method for subtyping breast tumors into the IntClust subtypes based on gene expression and demonstrate the clinical and biological validity of the IntClust classification. We developed a gene expression-based approach for classifying breast tumors into the ten IntClust subtypes by using the ensemble profile of the index discovery dataset. We evaluate this approach in 983 independent samples for which the combined copy-number and gene expression IntClust classification was available. Only 24 samples are discordantly classified. Next, we compile a consolidated external dataset composed of a further 7,544 breast tumors. We use our approach to classify all samples into the IntClust subtypes. All ten subtypes are observable in most studies at comparable frequencies. The IntClust subtypes are significantly associated with relapse-free survival and recapitulate patterns of survival observed previously. In studies of neo-adjuvant chemotherapy, IntClust reveals distinct patterns of chemosensitivity. Finally, patterns of expression of genomic drivers reported by TCGA (The Cancer Genome Atlas) are better explained by IntClust as compared to the PAM50 classifier. IntClust subtypes are reproducible in a large meta-analysis, show clinical validity and best capture variation in genomic drivers. IntClust is a driver-based breast cancer classification and is likely to become increasingly relevant as more targeted biological therapies become available.
      datePublished:2014-08-28T00:00:00Z
      dateModified:2014-08-28T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1186/s13059-014-0431-1
      keywords:
         Molecular Subtype
         Copy Number Data
         Cancer Cell Line Encyclopedia
         External Study
         Subtype Assignment
         Animal Genetics and Genomics
         Human Genetics
         Plant Genetics and Genomics
         Microbial Genetics and Genomics
         Bioinformatics
         Evolutionary Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-014-0431-1/MediaObjects/13059_2014_Article_431_Fig4_HTML.jpg
      isPartOf:
         name:Genome Biology
         issn:
            1474-760X
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:H Raza Ali
            affiliation:
                  name:University of Cambridge, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Cambridge
                  address:
                     name:Department of Pathology, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
                  name:Cambridge University Hospitals NHS
                  address:
                     name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Oscar M Rueda
            affiliation:
                  name:University of Cambridge, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suet-Feung Chin
            affiliation:
                  name:University of Cambridge, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christina Curtis
            affiliation:
                  name:University of Southern California
                  address:
                     name:Keck School of Medicine, University of Southern California, California, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark J Dunning
            affiliation:
                  name:University of Cambridge, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Samuel AJR Aparicio
            affiliation:
                  name:British Columbia Cancer Research Centre
                  address:
                     name:Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos Caldas
            affiliation:
                  name:University of Cambridge, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Cambridge, Addenbrooke’s Hospital
                  address:
                     name:Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
                     type:PostalAddress
                  type:Organization
                  name:Cambridge University Hospitals NHS
                  address:
                     name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Genome Biology
      issn:
         1474-760X
      volumeNumber:15
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Cambridge, Li Ka Shing Centre
      address:
         name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge
      address:
         name:Department of Pathology, University of Cambridge, Cambridge, UK
         type:PostalAddress
      name:Cambridge University Hospitals NHS
      address:
         name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge, Li Ka Shing Centre
      address:
         name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge, Li Ka Shing Centre
      address:
         name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:University of Southern California
      address:
         name:Keck School of Medicine, University of Southern California, California, USA
         type:PostalAddress
      name:University of Cambridge, Li Ka Shing Centre
      address:
         name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:British Columbia Cancer Research Centre
      address:
         name:Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, Canada
         type:PostalAddress
      name:University of Cambridge, Li Ka Shing Centre
      address:
         name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge, Addenbrooke’s Hospital
      address:
         name:Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
         type:PostalAddress
      name:Cambridge University Hospitals NHS
      address:
         name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:H Raza Ali
      affiliation:
            name:University of Cambridge, Li Ka Shing Centre
            address:
               name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
            name:University of Cambridge
            address:
               name:Department of Pathology, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
            name:Cambridge University Hospitals NHS
            address:
               name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Oscar M Rueda
      affiliation:
            name:University of Cambridge, Li Ka Shing Centre
            address:
               name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Suet-Feung Chin
      affiliation:
            name:University of Cambridge, Li Ka Shing Centre
            address:
               name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Christina Curtis
      affiliation:
            name:University of Southern California
            address:
               name:Keck School of Medicine, University of Southern California, California, USA
               type:PostalAddress
            type:Organization
      name:Mark J Dunning
      affiliation:
            name:University of Cambridge, Li Ka Shing Centre
            address:
               name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Samuel AJR Aparicio
      affiliation:
            name:British Columbia Cancer Research Centre
            address:
               name:Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:Carlos Caldas
      affiliation:
            name:University of Cambridge, Li Ka Shing Centre
            address:
               name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
            name:University of Cambridge, Addenbrooke’s Hospital
            address:
               name:Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
               type:PostalAddress
            type:Organization
            name:Cambridge University Hospitals NHS
            address:
               name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
      name:Department of Pathology, University of Cambridge, Cambridge, UK
      name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK
      name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
      name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
      name:Keck School of Medicine, University of Southern California, California, USA
      name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
      name:Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, Canada
      name:Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
      name:Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
      name:Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK

External Links {🔗}(194)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.12s.